CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical tria

Định dạng: PDF / Số trang: 13

Nhắn tin với admin nếu không tải được